Sareum Holdings Share Price (SAR)
| Bid price | 0.00 | Open price | 0.00 |
|---|---|---|---|
| Ask price | 0.00 | Prev close | 0.93 |
| High price | 0.00 | Spread | 0.00% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live Sareum Holdings share prices, Sareum Holdings stock quotes, charts, trades and FREE Sareum Holdings company fundamentals, market news and much much more. Why not upgrade to a premium service and get Sareum Holdings Level 2 Data, indepth research tools and investor commentary for Sareum Holdings (SAR) and other London Stock Exchange equities.
Sareum Holdings Share Price Chart
Register now for FREE Sareum Holdings share price charts
Sareum Holdings Share Price Information
| Name | Sareum Holdings | Epic | SAR |
|---|---|---|---|
| Activites | Discovers and develops therapeutic drugs by a combination of skills in biology, computational chemistry and medicinal chemistry | Reuters | SAR.L |
| ISIN | GB00B02RFS12 | Google Finance | LON:SAR |
| Share Price (p) | 0.00 | Prev. Share Price (p) | 0.93 |
|---|---|---|---|
| Shares in Issue (m) | 1,451 | Market Cap (£m) | 12 |
| PE Ratio (x) | Div per share (p) | 0.00 | |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | 0.00 | PEG |
Register now for FREE Sareum Holdings company fundamentals
Sareum Holdings Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 07/03/2011 | SELL | Tim Mitchell | CEO | 500,000 |
Sareum Holdings Company News
SYSTAR :Third Quarter Fiscal Year 2011-2012, St...
SYSTAR :Third Quarter Fiscal Year 2011-2012, Strong revenue momentum continues: +39% body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Third Quarter Fiscal Year 2011-2012 Strong revenue...
More Sareum Holdings Company News >>
Register now for FREE Sareum Holdings company news
Sareum Holdings Share Price Discussions
Sareum (SAR)
RHPS has just mentioned the above in an e-mail, they have gone up 240% today - started at 0.60 and finished up at 1.65. Look to be quite interesting.
oncology/agreement (SAR)
Specialist cancer drug discovery company, Sareum, and oncology-focused development and commercialisation company, Cancer Research Technology Limited, last week announced the publication of the latest results from their joint research collaboration with The Institute of Cancer Research. The...
New Chance For SAREUM (SAR) ??? (SAR)
Sareum is an experienced and specialist Structure-based Drug Discovery company. We accelerate and improve the productivity of both our in-house and our partners' discovery research using our proprietary approaches. Sareum has a highly experienced team with a track record of delivering high...
Register now for FREE Sareum Holdings share price discussions